Adam Brufsky, MD on MINDACT and HER2 Guidelines in Genomic Profiling #ASCO2020

Adam Brufsky, MD, PhD of University of Pittsburgh Cancer Institute discusses the MINDACT and HER2 guidelines in genomic profiling for breast cancer.